Previous editions:  200620072008200920102011 |  2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022
Galerie:  20062007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021

14. International EBHC Symposium 2019

EBHC, VBHC or Just Health Care?
Krakow, Poland, October 7-8, 2019

14. Międzynarodowe Sympozjum EBHC pt. EBHC, VBHC or Just Health Care? odbyło się w Krakowie w dniach 7-8 października 2019 roku w hotelu Park Inn, ul. Monte Cassino 2.

A hand-picked panel of experts from Poland and other countries presented the results of their studies and suggested proposals of solutions in 6 sessions:

  1. Better value care – wstęp wolny
  2. Innovative model of medical technology reimbursement
  3. Evidence or value – new models of health care services
  4. Prevention
  5. Real world data – many dimmensions
  6. Assessment in HTA – still new methodological challanges

Ze względu na szczególny walor edukacyjny wstęp na wykład otwierający był bezpłatny. Chcemy w ten sposób zachęcić do udziału w niej tych, którzy nie mogą wziąć udziału w całym Sympozjum – studentów oraz kolegów ze środowisk naukowych.

The idea of evidence-based healthcare has been our priority since the first editions of our Symposium. Fifteen years ago there was an urgent need of a widespread and multilateral discussion about EBHC in order to develop a common language for Poland to work on changes in the healthcare system. As evidence-based medicine and decision-making has gained popularity, dedicated public institutions and formal mechanisms were established. Modernised healthcare management focused on the need of improving health outcomes, but as a result of the need to master the economic part of the system, which was very urgent at that time, it began to have a financial and statistical character to an unprescedented extent in Poland.

The critics of the reforms took advantage of that and started to highlight the bureaucratic and “heartless” character of the new decision-making mechanisms. So the need to counterbalance the situation appeared and it was done by introducing value-based healthcare – an approach focused on the patient and health outcomes. The concept of value-based healthcare, relatively young in Poland, achieved recognition of many environments related to the healthcare system. However, without wide-scale and expensive governmental actions we will have no tools, namely nation-wide data collection (registers) and their analysis, to fully implement the idea. And so far we do not have them.

In this situation, we see an opportunity to reflect on the effects of the former, current and future changes. Maybe, despite the need for further development of EBHC and VBHC, it is worth to look back? Maybe we should descend from our lush scientific branches and clear away the leaves to look down on the earth and common roots. And those common roots are Just Healthcare – the oldest health care concept. The Great Mother and the source of all the subsequent healthcare system concepts. After years of evaluating health technologies and sincere belief in evidence, we will find out whether we are still heading in the right direction. Is our science and procedures still pursuing the aims of the original concept of Just Healthcare.

We met at the 14th EBHC (or maybe VBHC?) Symposium, this time to retrace our roots...

Partners
14. International EBHC Symposium 2019

Speakers
14. International EBHC Symposium 2019

Francis Arickx, Belgium  |  Małgorzata Bała, Poland  |  Stefan Bogusławski, Poland  |  John Eric Chaplin, Sweden  |  Carla Fernández Barceló, Spain  |  Jakub Gierczyński, Poland  |  Erica Ison, UK  |  Michał Jakubczyk, Poland  |  Tadeusz Jędrzejczyk, Poland  |  Grzegorz Juszczyk, Poland  |  Maria Libura, Poland  |  Joanna Łapa, Poland  |  Robert Plisko, Poland  |  Michał Rataj, Poland  |  Paulina Rolska-Wójcik, Poland  |  Przemysław Ryś, Poland  |  Stefan Sauerland, Germany  |  Małgorzata Skweres-Kuchta, Poland  |  Roman Topór-Mądry, Poland  |  Magdalena Władysiuk, Poland  |  Rafał Zasiewski, Poland

Francis Arickx

Francis Arickx
Head of the directorate Reimbursement of Medicines and Pharmaceutical Policy within the Health Care Department at the National Institute for Health and Disability Insurance (INAMI-RIZIV) in Belgium. He manages the departments responsible for administrative and scientific assessment and appraisal of reimbursement claims for medicines, orphan drugs and medical nutrition.
Francis Arickx is the former secretary general for the Commission for Reimbursement of Medicines and acts as representative/expert for the Institute and Belgium on a number of national and European platforms (NM CAPR, MEDEV, MoCA). He is one of the country coordinators for the BeNeLuxA Initiative www.beneluxa.org.
Francis graduated in pharmaceutical sciences from the University of Ghent, Belgium and teaches Health Policy in the Pharmaceutical Sciences Department at the University of Antwerp. top

Małgorzata Bała

Małgorzata Bała
Dr hab. Małgorzata Bała, prof. UJ jest pracownikiem Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie. Z zagadnieniami evidence-based healthcare jest związana od początku swojej pracy zawodowej. Jest współautorką rozdziałów w podręczniku pt. “Podstawy EBM, czyli medycyny opartej na danych naukowych dla lekarzy i studentów medycyny” (2008) oraz autorem wielu publikacji z zakresu przeglądów systematycznych. top

Stefan Bogusławski

Stefan Bogusławski
Physician, expert on the healthcare market, specialising in financing and strategy, as well as the pharmaceutical market.
Stefan Bogusławski has over 30 years of experience in market research and healthcare market consulting. He has managed Sequence and PEX PharmaSequence for over 10 years. Before that, between 1991 and 2007, he was a manager of the Polish and Central European branch of IMS Health and was in charge of Azyx – a research company.
He has been a speaker at industry conferences in Poland and abroad multiple times. He is also the author of publications in specialist and mass media concerning the Polish healthcare market, in particular the drug market.
Stefan Bogusławski is a graduate of the Medical University of Warsaw, he obtained the title of doctor of medicine in 1985. top

John Eric Chaplin

John Eric Chaplin
John Chaplin is an Associate Professor and Psychologist working for the Swedish Association of Local Authorities and Regions (SALAR), and the Sahlgrenska Academy at the University of Gothenburg, Sweden. He is the project leader for the translation and implementation of patient reported outcome measures Information System (PROMIS) into the Swedish health care system, and the Swedish health quality registries. He is supervising a research project into the development of a person-centred toolbox to aid patients in the evaluation of their health care and empower them to become co-producers of care. He has worked on Quality-Of-Life and PROM issues in national and international projects including DISABKIDS, KIDSCREEN and PROMIS. He has been Principal Investigator for European projects including the EU RESPECT project reviewing children’s needs in clinical trials research. He is currently co-chair of the International Society for Quality of Life’s Special Interest Group for Children and the PROMIS National Centre leader for Sweden. top

Carla Fernández Barceló

Carla Fernández Barceló
Carla is a Health Technology Assessment Technician of the Innovation Unit at Hospital Clínic de Barcelona, a high-tech hospital and a reference for health care, research and medical training in Spain. In her everyday job, she works with different projects (technologies, services) assessing both the clinical and economic outcomes, to prove the value of health care technologies that are being developed inside the hospital as well as new technologies candidate to be introduced in the Hospital.
Prior to this, Carla Fernandez was enrolled in d·Health Barcelona (Moebio, Biocat) a post-graduate program targeting innovation in healthcare, where she developed a 18-months project going through all the steps of the healthcare innovation cycle (detect a problem, create a solution, prototype, develop a business model and investor’s pitch to fund it).
Kontakt z sektorem innowacji w służbie zdrowia z punktu widzenia start-upu pokazał jej perspektywę, która jest przydatna w pracy w dziale HB-HTA i która uzupełniła wcześniejszą wiedzę na temat innowacji; punkt widzenia “sprzedawcy/start-upu” został uzupełniony perspektywą “kupującego/szpitala”. top

Jakub Gierczyński

Jakub Gierczyński
Doctor of medicine and MBA graduate of London School of Economics and Stockholm Business School. Expert with 20 years of experience in health economics, public health, disease management, decision analysis, medical audits, risk management (Burton, EBM, HTA and VBHC). Co-funder of the Polish Pharmacoeconomic Society, member of the Polish Society for Public Health, HTAi, ISPOR, the Polish Coalition for Personalised Medicine and IFIC Polska. Co-author of Polish HTA guidelines for drug technologies and member of the team preparing Polish HTA guidelines for medical devices. Author of several dozen of publications, studies and reports.https://www.researchgate.net/profile/Jakub_GierczynskiMember of international projects in the field of health policy, disease management and health economics. Expert and lecturer at the Institute of Health Care Management, the Health Care MBA and the Center of VBHC at the Łazarski University, He is also the owner of Doradztwo i ekspertyzy. top

Erica Ison

Erica Ison
Erica works at the Oxford Centre for Triple Value Healthcare (3V) in England. She has a decade’s experience in using the identification of unwarranted variation to increase value in the provision and delivery of health services. She was the Editor the NHS Atlases of Variation in Healthcare since the first compendium Atlas appeared under the English Department of Health’s Quality Innovation Improvement & Prevention (QIPP) programme in 2010. Since then, Erica has overseen the writing, editing and production of three compendium atlases and six specialist atlases, covering Liver Disease, Kidney Care, Children and Young People, Diagnostic Services, Respiratory Disease and Diabetes.
Erica is currently working on two projects in the National Health Service (NHS) to increase value in healthcare, one of which is focused on end-of-life care, and the other is focused on people with musculoskeletal conditions. On behalf of 3V, she will also be working on the European Union-funded ExACT Project for the next 4 years, collaborating with universities in Italy, The Netherlands, and Belgium together with other stakeholders in the healthcare sector.
In addition, Erica is the lead, and also a facilitator/trainer, for the Critical Appraisal Skills Programme (CASP) run by 3V.
Erica is a specialist in Health Impact Assessment (HIA) and in Health in All Policies (HiAP). Since 2003, she has worked as an expert adviser in HIA for the World Health Organization (WHO), and similarly in HiAP since 2008, and in the last few years has worked on three major projects relating to the health impacts of the construction and operation of nationally significant infrastructure for Public Health England. Erica was also part of the Global Burden of Disease (GBD) team for Public Health England (PHE) for two years.
In 2005, Erica won the Individual Award in Impact Assessment from the International Association for Impact Assessment, and in the same year was made an honorary member of the English Faculty of Public Health. top

Michał Jakubczyk

Michał Jakubczyk
Professor of the Warsaw School of Economics. He works in the Department of Decision Support and Analysis of the Warsaw School of Economics (SGH). He is also the co-owner of a consulting company called HealthQuest (www.healthquest.pl). He has a background in economics (MSc, PhD and habilitation in the Warsaw School of Economics) and mathematics (bachelor at the University of Warsaw). He spent a year in the Centre for Operations Research and Econometrics in Louvain-la-Neuve, Belgium (Marie Curie scholarship) and one semester in Tippie College of Business, University of Iowa, USA (Fulbright Senior Award). His scientific interests include researching health preferences, especially in the context of imprecise description of these preferences. He has published numerous scientific articles in the field of decision support, health economy and general decision theory (among others, in the Annals of Operations Research, Central European Journal of Operations Research, Health Economics, Pharmacoeconomics, Quality of Life Research, Value in Health (cf.: http://michaljakubczyk.pl)). He is a member of scientific associations such as The EuroQol Group and the International Academy of Health Preference Research (IAHPR). He led the winning team in the global health preference and choice modelling competition organised by IAHPR (http://iahpr.org/eq-dce-competition/). He gives lectures on decision analysis at bachelor, master’s and MBA levels, as well as training cuorses for various institutions (e.g. the National Health Fund, the Ministry of Health, the Agency for Health Technology Assessment and Tariffs, private companies). He co-directs the MBA programme offered jointly by the Warsaw School of Economics and the Medical University of Warsaw. top

Tadeusz Jędrzejczyk

Tadeusz Jędrzejczyk
Director of the Health Department of the Pomeranian Voivodeship Marshal's Office.
Graduate of the Medical Faculty of the Medical Academy in Gdańsk (nowadays known as the Medical University of Gdańsk). Specialist in Public Health. He has a PhD in medical sciences and holds the position of assistant professor in the Department of Public Health and Social Medicine. Author of several dozen articles on public health concerning, in particular, the field of management and organisation of health care, economic aspects and epidemiology.
Councilor of the City of Gdańsk (1994-1998) and chairman of the City Commission for Solving Alcohol Problems (1997-2001). Deputy Healthcare Director at the University Clinical Centre in Gdańsk (2010-2014), Deputy Director and then Director of the Pomeranian Branch of the National Health Fund (2008-2009 and then 2013/14); President of the National Health Fund between June 2014 and March 2016. top

Grzegorz Juszczyk

Grzegorz Juszczyk
Doctor of medical science, Director of National Institute of Public Health – National Institute of Hygiene. Since 2003 he is the scientist at Public Health Department at Warsaw Medical University. He co-operated with Medicover and LUX MED Groups, where he was responsible for planning and implementing health-benefited activities at work place. In LUX MED Group he leaded Health Education Office. He represented the Polish employers at the Advisory Committee of European Commission in relation to Health and Safety at work place.
top

Maria Libura

Maria Libura
Head of Medical Training and Simulation Centre, University of Warmia and Mazury in Olsztyn, vice-President of The Polish Society for Medical Communication, healthcare expert of the Jagiellonian Club Analytical Centre, President of Polish Prader–Willi Syndrome Association. top

Joanna Łapa

Joanna Łapa
Team Leader at HTA Registry. Before taking this position, she was a project coordinator at CEESTAHC and an analyst at MedInvest Scanner as well as the Watch Health Care Foundation. She graduated from Public Health and Administration studies. top

Robert Plisko

Robert Plisko
President of HTA Consulting since 2006, he is one of the founders of the company. Robert - master of economy by education (Cracow University of Economics), started his career in the Polish National Centre for Quality Assessment in Health Care. Robert is the author of many publications on HTA and health care and as advisor to the World Bank he participated in projects conducted in Serbia. Robert heads the Economic Analyses Department and carries out projects in Asia and Australia. Calm and common sense are Robert's second nature. top

Michał Rataj

Michał Rataj
Graduated from the Faculty of Computer Science at the University of Silesia, profession IT specialist. As a patient, actively involved in patient organizations for over 20 years. Board Member of European Patients Forum (EPF). I am also pleased to represent EPF in Patients’ and Consumers’ Working Party (PCWP) within the European Medicines Agency (EMA). Through the EMA, I am involved in various projects as digital and media working group, electronic product information, vaccination and more. I am also a board member of the Polish Neuromuscular Diseases Association (PTCHNM) and European Alliance of Muscular Dystrophy Associations (EAMDA Slovenia). Co-organiser of many international and national conferences for patients with neuro - muscular diseases. Co-author of publication:“Be an ambassador for change that you would like to see”: a call to action to all stakeholders for co-creation in healthcare and medical research to improve quality of life of people with a neuromuscular disease (Orphanet Journal of Rare Diseases). In private life - enthusiast of modern technologies and modern devices facilitating mobility. top

Paulina Rolska
Paulina Rolska-Wójcik Business development & project manager w firmie HTA Consulting. Poprzednio specjalista ds. ekonomiki zdrowia w dziale Market Access w GlaxoSmithKline. Od 2014 do 2016 roku współpracowała z firmą MedInvest Scanner, zajmującą się oceną ryzyka inwestycyjnego w innowacyjne nielekowe technologie medyczne oraz due diligence. W latach 2013-2014 audytor w firmie HTA Audit zajmującej się oceną jakości analiz wchodzących w skład raportu HTA. Z wykształcenia doktor nauk o zdrowiu. Autorka wielu publikacji. top
Przemysław Ryś

Przemysław Ryś
The Clinical Analyses Department's Director in HTA Consulting. A doctor by education, he graduated from Collegium Medicum of the Jagiellonian University and worked in the J. Dietl Specialist Hospital in Krakow and the Krakow University Hospital. Przemysław heads the Clinical Analyses Department and supervises projects carried out in Poland and the rest of Europe. He is the author of clinical and methodical publications as well as a reviewer of scientific journals. He has a great eye for detail and the ability to ask inquisitive clinical and methodical questions. top

Stefan Sauerland

Stefan Sauerland
Stefan Sauerland joined IQWiG (Institute for Quality and Efficiency in Healthcare) in January 2010. Heading the Non-Drug Interventions Department, he is responsible for the scientific evaluation of non-drug therapies (including medical devices), diagnostic tests, and screening procedures. Within the German health care system, IQWiG is responsible for producing evidence-based reports, which inform reimbursement decisions on a national level.
Prof Sauerland has 12 years of experience in surgical research, first at University of Cologne, then at Witten/Herdecke University. His focus was on clinical studies, clinical guidelines, and meta-analyses. He has published over 250 papers, of which more than 150 are indexed in Medline. In 2005, he was awarded the DKV Cochrane Prize for a Cochrane review on laparoscopic appendectomy. He holds an M.D. from University of Cologne and an M.P.H. from Düsseldorf University. In 2019, he was granted an adjunct professorship by University of Cologne. top

Małgorzata Skweres- Kuchta

Małgorzata Skweres-Kuchta
PhD in economics, professionally involved with the University of Szczecin; her field of work involves management of healthcare systems and support for children with rare diseases; member of the Council of Experts on Rare Diseases at Medyczna Racja Stanu (Medical National Interest, Polish think-tank), CEO of Platynowa Drużyna (Platinum Team Foundation) – patient organisation for patients with type 2 neuronal ceroid lipofuscinosis (CLN2); member of the NCL Gruppe Deutschland e.V. patient organisation. top

Roman Topór-Mądry

Roman Topór-Mądry
Roman Topór-Mądry, MD – President of the Agency for Health Technology Assessment and Tariff System. Doctor, specialist in public health, epidemiologist. Regional consultant in public health for the Małopolskie voivodeship. Deputy Director of the Institute of Public Health of the Faculty of Health Sciences at the Jagiellonian University Medical College. Participant and coordinator of many research projects, he worked in advisory teams to, i.a. the Ministry of Health, scientific societies, local governments, the European Commission, the World Bank. top

Magdalena Władysiuk

Magdalena Władysiuk
President of CEESTAHC Society, CEO of MedInvest Scanner, Vice President of HTA Consulting.In HTA Consulting, she is responsible for the strategic development of the company through research and services development, new product launch and marketing. Ms. Wladysiuk main and primary aim is to provide high quality information or data based on evidence based medicine or health technology assessment methodology not only in Poland but in Europe and Asia. Key role of her work is to improve patient outcomes through better healthcare decisions.
In CEESTAHC she was responsible for the establishing and providing wide connection platform for discussion for all stakeholders in health care system. CEESTAHC mission is to improve the quality of health care systems value with the use of evidence.
She graduatd Medical Academy in Lublin and MBA, economy in Kozminski Academy in Warsaw.
She was Member of HTAi Annual Meeting in 2006-2008. top

Rafał Zasiewski

Rafał Zasiewski
Rafał has been gaining experience and achieving successes in managerial positions in sales and marketing since 1999. For 15 years, he was associated with the Swiss pharmaceutical company Novartis. In 2011, as a leader of an international team of ophthalmic drug managers in Novartis, he built and developed marketing strategies in the Netherlands, Denmark, Norway, Finland, Sweden and Poland. He has introduced projects to optimise operations and manage product strategy in the face of the emergence of competition on the market. Since 2015, he has been co-creating Ideal Datum; the company’s flagship product is Compass Point-Clinics Audit – a consultancy service based on Swiss standards, providing Polish entrepreneurs with a professional tool supporting operational efficiency. As part of his business, he also audits the effectiveness of sales and marketing teams in medical and pharmaceutical companies. top

Download
14. International EBHC Symposium 2019

Previous editions

EBHC 2006 archiwum

Zobacz edycję 2006

EBHC 2007 archiwum

Zobacz edycję 2007

EBHC 2008 archiwum

Zobacz edycję 2008

EBHC 2009 archiwum

Zobacz edycję 2009

Zobacz edycję 2010

Zobacz edycję 2011

Zobacz edycję 2012

Zobacz edycję 2013

Zobacz edycję 2014

Zobacz edycję 2015

Zobacz edycję 2016

Zobacz edycję 2017

Zobacz edycję 2018

Zobacz edycję 2019

Zobacz edycję 2020

Zobacz edycję 2021

Zobacz edycję 2022

en_GBEnglish (UK)